6U41

1.7 angstrom structure of a pathogenic human Syt 1 C2B (D304G)

6U41 の概要

• エントリーDOI: 10.2210/pdb6u41/pdb
• 関連するPDBエントリー: 1UOW
• 分子名称: Synaptotagmin-1, SULFATE ION (3 entities in total)
• 機能のキーワード: c2 domain, c2b, greek key, exocytosis
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 18302.10

構造登録者

Dominguez, M.J.,Bradberry, M.M.,Chapman, E.R.,Sutton, R.B. (登録日: 2019-08-22, 公開日: 2020-05-13, 最終更新日: 2023-10-11)

主引用文献

Bradberry, M.M.,Courtney, N.A.,Dominguez, M.J.,Lofquist, S.M.,Knox, A.T.,Sutton, R.B.,Chapman, E.R.
Molecular Basis for Synaptotagmin-1-Associated Neurodevelopmental Disorder.
Neuron, 107:52-64.e7, 2020

PubMed Abstract: At neuronal synapses, synaptotagmin-1 (syt1) acts as a Ca sensor that synchronizes neurotransmitter release with Ca influx during action potential firing. Heterozygous missense mutations in syt1 have recently been associated with a severe but heterogeneous developmental syndrome, termed syt1-associated neurodevelopmental disorder. Well-defined pathogenic mechanisms, and the basis for phenotypic heterogeneity in this disorder, remain unknown. Here, we report the clinical, physiological, and biophysical characterization of three syt1 mutations from human patients. Synaptic transmission was impaired in neurons expressing mutant variants, which demonstrated potent, graded dominant-negative effects. Biophysical interrogation of the mutant variants revealed novel mechanistic features concerning the cooperative action, and functional specialization, of the tandem Ca-sensing domains of syt1. These mechanistic studies led to the discovery that a clinically approved K channel antagonist is able to rescue the dominant-negative heterozygous phenotype. Our results establish a molecular cause, basis for phenotypic heterogeneity, and potential treatment approach for syt1-associated neurodevelopmental disorder.

PubMed: 32362337
DOI: 10.1016/j.neuron.2020.04.003

実験手法

X-RAY DIFFRACTION (1.7 Å)